TABLE OF CONTENTS
Volume 9, Issue 3 (June 2009)
Review
Pharmacogenetics and biomarkers in colorectal cancer
A S Strimpakos, K N Syrigos and M W Saif
Pharmacogenomics J 9: 147-160; advance online publication, April 21, 2009; doi:10.1038/tpj.2009.8
Original Articles
TNF-
-308 G/A polymorphism and responsiveness to TNF- blockade therapy in moderate to severe rheumatoid arthritis: a systematic review and meta-analysis
D D O'Rielly, N M Roslin, J Beyene, A Pope and P Rahman
Pharmacogenomics J 9: 161-167; advance online publication, April 14, 2009; doi:10.1038/tpj.2009.7
Association study of tardive dyskinesia and five DRD4 polymorphisms in schizophrenia patients
C C Zai, A K Tiwari, V Basile, V De Luca, D J Müller, N King, A N Voineskos, G Remington, H Y Meltzer, J A Lieberman, S G Potkin and J L Kennedy
Pharmacogenomics J 9: 168-174; advance online publication, February 24, 2009; doi:10.1038/tpj.2009.2
CYP2D6 genotype and its relationship with metoprolol dose, concentrations and effect in patients with systolic heart failure
C F Sharp, S J Gardiner, B P Jensen, R L Roberts, R W Troughton, J G Lainchbury and E J Begg
Pharmacogenomics J 9: 175-184; advance online publication, April 14, 2009; doi:10.1038/tpj.2009.9
Functional analysis of a mutation in the SLCO1B1 gene (c.1628T>G) identified in a Japanese patient with pravastatin-induced myopathy
Tomomi Furihata, Naoki Satoh, Tomoharu Ohishi, Miyuki Ugajin, Yoshio Kameyama, Kaori Morimoto, Sayaka Matsumoto, Keiko Yamashita, Kaoru Kobayashi and Kan Chiba
Pharmacogenomics J 9: 185-193; advance online publication, February 24, 2009; doi:10.1038/tpj.2009.3
Influence of the G2677T/C3435T haplotype of MDR1 on P-glycoprotein trafficking and ibutilide-induced block of HERG
B F McBride, T Yang and D M Roden
Pharmacogenomics J 9: 194-201; advance online publication, February 10, 2009; doi:10.1038/tpj.2009.1
GNAS1 T393C polymorphism is associated with histopathological response to neoadjuvant radiochemotherapy in esophageal cancer
H Alakus, U Warnecke-Eberz, E Bollschweiler, S P Mönig, D Vallböhmer, J Brabender, U Drebber, S E Baldus, K Riemann, W Siffert, A H Hölscher and R Metzger
Pharmacogenomics J 9: 202-207; advance online publication, March 10, 2009; doi:10.1038/tpj.2009.5
Allele-specific expression and gene methylation in the control of CYP1A2 mRNA level in human livers
Roza Ghotbi, Alvin Gomez, Lili Milani, Gunnel Tybring, Ann-Christine Syvänen, Leif Bertilsson, Magnus Ingelman-Sundberg and Eleni Aklillu
Pharmacogenomics J 9: 208-217; advance online publication, March 10, 2009; doi:10.1038/tpj.2009.4
Corrigendum
Transcription factor-binding sites in the thymidylate synthase gene: predictors of outcome in patients with metastatic colorectal cancer treated with 5-fluorouracil and oxaliplatin? FREE
L Paré, E Marcuello, A Altés, E del Rio, L Sedano, A Barnadas and M Baiget
Pharmacogenomics J 9: 218; doi:10.1038/tpj.2009.17
